{"filing":{"accession_number":"0001193125-26-332982","cik":"0001158895","ticker":"LMAT","company_name":"LEMAITRE VASCULAR INC","form":"8-K","filing_date":"2026-08-04","report_date":"2026-08-04","primary_document":"d320964d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1158895/000119312526332982/d320964d8k.htm"},"events":[{"id":23689,"run_id":21422,"accession_number":"0001193125-26-332982","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"LeMaitre Vascular issued a press release on August 4, 2026 disclosing preliminary Q2 2026 financial results, including net sales of $70.4mm (+10%), gross margin of 72.1%, operating income of $20.4mm (+26%), and diluted EPS of $0.74 (+23%), along with forward guidance for Q3, Q4, and full-year 2026. The filing includes condensed consolidated financial statements and is a classic Item 2.02 earnings disclosure.","company_name":"LEMAITRE VASCULAR INC","ticker":"LMAT","filing_date":"2026-08-04","form":"8-K","submitted_at":null,"items":[{"id":23994,"accession_number":"0001193125-26-332982","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"LeMaitre Vascular issued a press release on August 4, 2026 disclosing preliminary Q2 2026 financial results, including net sales of $70.4mm (+10%), gross margin of 72.1%, operating income of $20.4mm (+26%), and diluted EPS of $0.74 (+23%), along with forward guidance for Q3, Q4, and full-year 2026. The filing includes condensed consolidated financial statements and is a classic Item 2.02 earnings disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T00:25:05.411210+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":23994,"accession_number":"0001193125-26-332982","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"LeMaitre Vascular issued a press release on August 4, 2026 disclosing preliminary Q2 2026 financial results, including net sales of $70.4mm (+10%), gross margin of 72.1%, operating income of $20.4mm (+26%), and diluted EPS of $0.74 (+23%), along with forward guidance for Q3, Q4, and full-year 2026. The filing includes condensed consolidated financial statements and is a classic Item 2.02 earnings disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T00:25:05.411210+00:00","company_name":"LEMAITRE VASCULAR INC","ticker":"LMAT","filing_date":"2026-08-04"}]}